ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy.

MLA

Bittar, Peter G., et al. “ASFA Category IV Becomes Category I: Idiopathic Thrombotic Thrombocytopenic Purpura in a Patient with Presumed Gemcitabine-Induced Thrombotic Microangiopathy.” Journal of Clinical Apheresis, vol. 33, no. 3, June 2018, pp. 423–26. EBSCOhost, https://doi.org/10.1002/jca.21590.

APA

Bittar, P. G., Nickolich, M. S., & Onwuemene, O. A. (2018). ASFA Category IV becomes Category I: Idiopathic thrombotic thrombocytopenic purpura in a patient with presumed gemcitabine-induced thrombotic microangiopathy. Journal of Clinical Apheresis, 33(3), 423–426. https://doi.org/10.1002/jca.21590

Chicago

Bittar, Peter G, Myles S Nickolich, and Oluwatoyosi A Onwuemene. 2018. “ASFA Category IV Becomes Category I: Idiopathic Thrombotic Thrombocytopenic Purpura in a Patient with Presumed Gemcitabine-Induced Thrombotic Microangiopathy.” Journal of Clinical Apheresis 33 (3): 423–26. doi:10.1002/jca.21590.